SMOC2 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9H3U7 |
---|---|
Clone Names | 110717188 |
Gene ID | 64094 |
---|---|
Other Names | SPARC-related modular calcium-binding protein 2, Secreted modular calcium-binding protein 2, SMOC-2, Smooth muscle-associated protein 2, SMAP-2, SMOC2, SMAP2 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | SMOC2 |
---|---|
Synonyms | SMAP2 |
Function | Promotes matrix assembly and cell adhesiveness (By similarity). Can stimulate endothelial cell proliferation, migration, as well as angiogenesis. |
Cellular Location | Secreted, extracellular space, extracellular matrix, basement membrane |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes a member of the SPARC family (secretedprotein acidic and rich in cysteine/osteonectin/BM-40), which arehighly expressed during embryogenesis and wound healing. The geneproduct is a matricellular protein which promotes matrix assemblyand can stimulate endothelial cell proliferation and migration, aswell as angiogenic activity. Associated with pulmonary function,this secretory gene product contains a Kazal domain, twothymoglobulin type-1 domains, and two EF-hand calcium-bindingdomains. The encoded protein may serve as a target for controllingangiogenesis in tumor growth and myocardial ischemia. Alternativesplicing results in multiple transcript variants. [provided byRefSeq].
References
Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :Birlea, S.A., et al. J. Invest. Dermatol. 130(3):798-803(2010)Wilk, J.B., et al. Am. J. Respir. Crit. Care Med. 175(6):554-560(2007)Rocnik, E.F., et al. J. Biol. Chem. 281(32):22855-22864(2006)Vannahme, C., et al. Biochem. J. 373 (PT 3), 805-814 (2003) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.